Online inquiry

IVTScrip™ mRNA-Human ARHGEF19, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK25612MR)

This product GTTS-WK25612MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ARHGEF19 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_153213.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 128272
UniProt ID Q8IW93
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGEF19, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK25612MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK21223MR IVTScrip™ mRNA-Human ANKRD37, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD37
GTTS-WK10159MR IVTScrip™ mRNA-Human ADORA2A, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADORA2A
GTTS-WK10430MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK24182MR IVTScrip™ mRNA-Human ARRDC4, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARRDC4
GTTS-WK22967MR IVTScrip™ mRNA-Human ARPC2, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARPC2
GTTS-WK25071MR IVTScrip™ mRNA-Human ARPC5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARPC5
GTTS-WK25004MR IVTScrip™ mRNA-Human ARHGDIA, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGDIA
GTTS-WK20368MR IVTScrip™ mRNA-Human AOAH, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AOAH
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW